Stockscreener 앱 받기
0.19
5.00%
-0.01
시간 외 거래:
.19
전일 마감가:
$0.20
열려 있는:
$0.2002
하루 거래량:
15.49M
Relative Volume:
2.02
시가총액:
$25.76M
수익:
$1.47M
순이익/손실:
$-23.06M
주가수익비율:
-0.8355
EPS:
-0.2274
순현금흐름:
$-19.64M
1주 성능:
-3.11%
1개월 성능:
-7.32%
6개월 성능:
-72.06%
1년 성능:
-65.89%
1일 변동 폭
$0.18
$0.2129
1주일 범위
$0.18
$0.3029
52주 변동 폭
$0.17
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
명칭
VolitionRX Ltd
전화
646 650 1351
주소
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.19 | 27.11M | 1.47M | -23.06M | -19.64M | -0.2274 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-08 | 개시 | H.C. Wainwright | Buy |
| 2023-02-01 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-02-17 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-03-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-05-16 | 개시 | Maxim Group | Buy |
| 2018-05-14 | 재확인 | The Benchmark Company | Buy |
| 2016-09-07 | 재확인 | Rodman & Renshaw | Buy |
| 2016-02-01 | 개시 | Rodman & Renshaw | Buy |
모두보기
VolitionRX Ltd 주식(VNRX)의 최신 뉴스
VNRX Receives Unchanged 'Buy' Rating from D. Boral Capital | VNR - GuruFocus
These stocks are the most active in today's session - ChartMill
Aug Drivers: What is the cash position of VolitionRx Limited2026 Biggest Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
Stock Market Volume Leaders: Nasdaq, NYSE, and NYSE American Trading ActivityNews and Statistics - IndexBox
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Discovery - Blockonomi
VolitionRx (VNRX) Stock Soars 70% on Liquid Biopsy Breakthrough - parameter.io
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Detection Method - MoneyCheck
VolitionRx (VNRX) Stock Surges 70% After Cancer DNA Breakthrough - CoinCentral
Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA - Financial Times
VolitionRx Ltd Stock (ISIN: US92852X1037) Faces Prolonged Uncertainty Amid Diagnostics Stagnation - AD HOC NEWS
VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill
VolitionRX (VNRX) Stock Price, News & Analysis - MarketBeat
VolitionRX: Navigating the Path from Innovation to Market Adoption () - aktiencheck.de
VolitionRx announces automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems - Yahoo Finance
VolitionRx shares jump as feline cancer blood test delivers strong accuracy results - MSN
VolitionRx (VNRX) Completes Key Phase for Nu.Q Vet Cancer Test i - GuruFocus
Volition announces first ever automated Nu.Q® Vet cancer test with Fujifilm Vet Systems - marketscreener.com
Automated cancer screening test set for Japan’s 7M pet dogs - Stock Titan
Tax withholding on VolitionRx (VNRX) shares for officer via RSU settlement - Stock Titan
VolitionRx (VNRX) CCO covers tax bill via 2,283-share cancellation - Stock Titan
Tax withholding trims VolitionRx (VNRX) GC Nicholas Plummer’s shares - Stock Titan
VNRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
VolitionRx issues shares to satisfy debt obligations and completes private placement - Investing.com
VNRX SEC FilingsVolitionrx 10-K, 10-Q, 8-K Forms - Stock Titan
VolitionRx (VNRX) grants CCO 149,000 RSUs in lieu of cash pay - Stock Titan
Ethel Rubin receives 178,000 RSU award at VolitionRx Ltd (VNRX) - Stock Titan
Executive at VolitionRx (VNRX) awarded 142,000 RSUs in lieu of cash pay - Stock Titan
VOLITIONRX (VNRX) CFO awarded 202,000 RSUs in lieu of cash pay - Stock Titan
119,000 RSUs granted to VolitionRx (VNRX) secretary in lieu of cash pay - Stock Titan
VolitionRx (VNRX) grants 187,000 RSUs to General Counsel Plummer - Stock Titan
[Form 4] VOLITIONRX LTD Insider Trading Activity - Stock Titan
VolitionRx (VNRX) executive receives 173,000 RSUs instead of cash pay - Stock Titan
VolitionRx (VNRX) grants CSO 149,000 RSUs instead of cash - Stock Titan
Director at VolitionRx (VNRX) granted 178,000 RSUs in lieu of cash - Stock Titan
VolitionRx advances cancer tests, expects French reimbursement By Investing.com - Investing.com Australia
VolitionRx Reports Clinical and Commercial Progress Across Cancer Detection and Sepsis Monitoring Platforms - citybuzz -
VolitionRx advances cancer tests, expects French reimbursement - Investing.com
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution - Yahoo Finance
VolitionRx issues shares to satisfy debt and completes private placement - Investing.com South Africa
VolitionRx (NYSE: VNRX) issues shares to repay Lind note - Stock Titan
Q3 2025 VolitionRX Ltd Earnings Call Transcript - GuruFocus
Should You Buy VolitionRX Ltd (VNRX) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
Armistice Capital reports 4.99% stake in VolitionRx (VNRX) — 6.45M shares - Stock Titan
Guidance Update: Is VolitionRx Limited gaining market share2025 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
Volume Summary: Is now the right time to enter VolitionRx LimitedJuly 2025 Retail & Step-by-Step Trade Execution Guides - mfd.ru
VolitionRx nears 100 Nu.Q Discover clients, extends reach to Japan - Stock Titan
VolitionRx receives NYSE American non-compliance notice By Investing.com - Investing.com Australia
VolitionRx (VNRX) Plans to Offer Nearly 18 Million Shares - GuruFocus
VolitionRx (VNRX) Faces NYSE American Compliance Challenge - GuruFocus
VolitionRx Gets NYSE American Non-Compliance Notice for Failing Equity Requirements - marketscreener.com
VolitionRX Ltd (VNRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.55%
2.50%
자본화:
|
볼륨(24시간):